The UK patent office has issued the Kalyptix® patent (GB1914184.5) covering an immune-protective bilayer membrane. We use the Kalyptix technology platform to create implantable devices for cell therapy which act as a barrier to cells yet permit diffusion of molecules such as glucose and insulin.
In addition, the European patent office has issued the microscaffold patent (16804859.3). Our custom microscaffolds can be made from a variety of materials and have open, porous, three-dimensional structure allowing for facile cell attachment and integration over a large range of cell types. They have applications as injectable cell carriers in cell therapy and as micro-tissues in high-throughput cell culture.
